Ridgeline Therapeutics
Manufacturing · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2109 Post Office St Ste 331, Galveston, ...Phone Number
(832) 613-5356Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Ridgeline Therapeutics
Ridgeline Therapeutics is a Houston-based biotech company focused on developing innovative drugs that target mechanisms to reverse age-related muscle weakness, Type 2 diabetes, obesity, muscular dystrophies, and kidney disease. The company specializes in creating first-in-class small molecule inhibitors of nicotinamide N-methyltransferase (NNMT) to regulate energy metabolism and epigenetic pathways. Their pipeline includes transformative once-daily oral medications aimed at addressing chronic health issues such as musculoskeletal disorders and metabolic diseases. Ridgeline Therapeutics is committed to revolutionizing healthcare through its advanced biotechnology solutions.Explore more
Ridgeline Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ridgeline Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Ridgeline Therapeutics had a recent Job posting/layoffs
Check if Ridgeline Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Ridgeline Therapeutics
Funding: Get notified immidiatlly once Ridgeline Therapeutics has new funding data
Ridgeline Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Ridgeline Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Ridgeline Therapeutics recently announced quarterly report
Product Launch: Get notified when Ridgeline Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Ridgeline Therapeutics
Find 3 more new buyers
Compare Similar Companies to Ridgeline Therapeutics
Compare insights from companies similar to Ridgeline Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ridgeline Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ridgeline Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ridgeline Therapeutics.
Ridgeline Therapeutics Tech Stack
A closer look at the technologies used by Ridgeline Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ridgeline Therapeutics
Sign Up For FreeTo access detailed company insights
Ridgeline Therapeutics is a Houston-based biotech company focused on developing innovative drugs that target mechanisms to reverse age-related muscle weakness, Type 2 diabetes, obesity, muscular dystrophies, and kidney disease. The company specializes in creating first-in-class small molecule inhibitors of nicotinamide N-methyltransferase (NNMT) to... Read More
